Determining the Effect of Non-Thermal Plasma on the Transmembrane Kinetics of Melittin through Molecular Explorations

Yanxiu Cui1, Tong Zhao1, Yanxiong Niu1

  • 1School of Electrical Engineering, Shandong University, Ji'nan 250061, China.

Biomolecules
|October 26, 2024
PubMed

Insights

Non-thermal plasma (NTP) enhances melittin (MEL) anticancer effects by improving its membrane binding and reducing side effects. This combination shows promise for clinical applications in plasma biomedicine.

Area of Science:

  • Plasma biomedicine
  • Biochemistry
  • Cancer research

Background:

  • Melittin (MEL) exhibits anticancer properties but faces clinical limitations due to its controversial activity.
  • Non-thermal plasma (NTP) is explored for synergistic anticancer strategies.

Purpose of the Study:

  • To investigate the transmembrane process and mechanism of MEL activity in various cell systems.
  • To evaluate the synergistic potential of combining MEL with NTP for cancer therapy.

Main Methods:

  • Studied the interaction of MEL with lipid bilayers to understand its orientation and binding.
  • Investigated the influence of sialic acid overexpression on MEL membrane interaction.
  • Assessed the combined effects of MEL and NTP on cancer cells.

Main Results:

  • Electrostatic attraction stabilizes MEL orientation on cell membranes.
  • Sialic acid levels impact MEL binding and membrane stability.
  • NTP reduces the required MEL dosage and its non-specific cytotoxic effects.

Conclusions:

  • The study provides theoretical support for enhancing MEL's clinical applicability.
  • Combining MEL with NTP offers a promising strategy for cancer treatment in plasma biomedicine.